Skip to content
Clinical Trials – home
BulgariaBack to Bulgaria

Clinical trials in Velingrad

6 clinical trials in Velingrad, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.

Velingrad at a glance
6
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

6 trials in Velingrad

Open in trial search

Obesity+1

Recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:MOLNUPIRAVIR
  • Sponsor:Merck Sharp & Dohme LLC
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Human Igg1 Kappa Monoclonal Antibody Against Crlf2
  • Sponsor:Upstream Bio Inc.

Asthma

Not recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Atuliflapon
  • Sponsor:AstraZeneca AB
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Obicetrapib
  • Sponsor:NewAmsterdam Pharma B.V.

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Velingrad

What the registry says about research in the country

01 Respiratory Research

Innovative studies focusing on moderate to severe asthma treatments, including trials of novel therapeutics like Atuliflapon and Dexpramipexole for improving patient outcomes.

  • Uncontrolled Asthma Management
  • Eosinophilic Asthma Treatment
  • Exacerbation Reduction Strategies

Research aims to enhance treatment options for patients with severe respiratory conditions.

02 Cardiovascular Studies

Groundbreaking research examining atherosclerotic cardiovascular disease treatments, with focus on evaluating new lipid-modifying therapies using obicetrapib.

  • Major Cardiovascular Events Prevention
  • Lipid Management
  • Coronary Risk Reduction

Studies target improved outcomes for patients with established cardiovascular conditions.

03 Infectious Disease Research

Critical investigations into COVID-19 treatments, specifically testing molnupiravir in non-hospitalized adults at high risk for severe illness.

  • Viral Infection Management
  • Outpatient Treatment Options
  • Disease Progression Prevention

Research focuses on reducing hospitalization rates and improving patient outcomes.

04 Allergy Studies

Comprehensive research on allergic rhinitis and rhinoconjunctivitis, evaluating subcutaneous immunotherapy for house dust mite allergies.

  • Immunotherapy Effectiveness
  • Allergic Response Management
  • Combined Symptom Control

Trials aim to improve quality of life for patients with moderate to severe allergic conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.